Detalhe da pesquisa
1.
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Cancer
; 125(3): 424-433, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30359477
2.
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
J Neurooncol
; 129(3): 487-494, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27406589
3.
Wound healing complications in brain tumor patients on Bevacizumab.
J Neurooncol
; 124(3): 501-6, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26298437
4.
Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines.
J Proteome Res
; 13(1): 191-9, 2014 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24266786
5.
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
J Neurooncol
; 119(1): 135-40, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24803001
6.
The role of inflammation in brain cancer.
Adv Exp Med Biol
; 816: 75-105, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24818720
7.
Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium.
J Proteome Res
; 12(1): 135-50, 2013 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23249167
8.
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.
Cancer
; 119(15): 2747-53, 2013 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23633392
9.
Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma.
Cancer
; 118(14): 3599-606, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22086614
10.
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway.
J Neurooncol
; 107(3): 487-501, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22249692
11.
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor.
Cancer
; 117(21): 4939-47, 2011 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480200
12.
Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma.
J Neurooncol
; 102(2): 273-80, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20652724
13.
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation.
J Proteome Res
; 9(5): 2098-108, 2010 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-20199106
14.
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells.
J Proteome Res
; 9(1): 430-43, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19899826
15.
Polar lipid remodeling and increased sulfatide expression are associated with the glioma therapeutic candidates, wild type p53 elevation and the topoisomerase-1 inhibitor, irinotecan.
Glycoconj J
; 27(1): 27-38, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19557511
16.
Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
J Neurooncol
; 94(2): 229-34, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19267183
17.
A novel small molecule inhibitor of signal transducers and activators of transcription 3 reverses immune tolerance in malignant glioma patients.
Cancer Res
; 67(20): 9630-6, 2007 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17942891
18.
VEGF Trap induces antiglioma effect at different stages of disease.
Neuro Oncol
; 10(6): 940-5, 2008 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-18708344
19.
Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.
Neuro Oncol
; 10(2): 216-22, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18314417
20.
A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.
Neuro Oncol
; 10(2): 208-15, 2008 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-18316473